Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Renal Insufficiency, Chronic | 15 | 2024 | 2306 | 1.790 |
Why?
|
Nephrolithiasis | 3 | 2020 | 117 | 1.420 |
Why?
|
Glomerular Filtration Rate | 10 | 2023 | 2232 | 1.290 |
Why?
|
Albuminuria | 3 | 2015 | 659 | 1.030 |
Why?
|
Kidney Diseases | 5 | 2023 | 2100 | 0.970 |
Why?
|
Kidney Glomerulus | 2 | 2020 | 567 | 0.930 |
Why?
|
Hyponatremia | 3 | 2020 | 278 | 0.870 |
Why?
|
Kidney | 10 | 2023 | 7072 | 0.840 |
Why?
|
Renal Insufficiency | 4 | 2019 | 810 | 0.790 |
Why?
|
Nephrology | 4 | 2021 | 270 | 0.770 |
Why?
|
Kidney Tubules | 2 | 2020 | 453 | 0.750 |
Why?
|
Hypophosphatemia, Familial | 1 | 2020 | 32 | 0.710 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2020 | 44 | 0.710 |
Why?
|
Acute Kidney Injury | 7 | 2021 | 1943 | 0.620 |
Why?
|
Amino Acid Transport Systems, Basic | 1 | 2017 | 35 | 0.560 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2020 | 334 | 0.560 |
Why?
|
Biopsy | 6 | 2021 | 6768 | 0.530 |
Why?
|
Arteriosclerosis | 1 | 2020 | 1055 | 0.520 |
Why?
|
Hyperkalemia | 2 | 2023 | 233 | 0.510 |
Why?
|
Kidney Medulla | 1 | 2015 | 169 | 0.490 |
Why?
|
Nephrectomy | 1 | 2020 | 928 | 0.490 |
Why?
|
Anemia | 2 | 2023 | 1514 | 0.440 |
Why?
|
Creatinine | 7 | 2023 | 1916 | 0.430 |
Why?
|
Lupus Nephritis | 3 | 2021 | 323 | 0.410 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2012 | 2057 | 0.400 |
Why?
|
Rhabdomyolysis | 1 | 2013 | 150 | 0.400 |
Why?
|
Vitamin B 12 | 1 | 2015 | 531 | 0.380 |
Why?
|
Oleanolic Acid | 1 | 2011 | 43 | 0.380 |
Why?
|
Homocysteine | 1 | 2015 | 638 | 0.380 |
Why?
|
Crohn Disease | 1 | 2023 | 2281 | 0.360 |
Why?
|
Amino Acids | 1 | 2017 | 1710 | 0.360 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2431 | 0.310 |
Why?
|
Peptides | 2 | 2014 | 4338 | 0.310 |
Why?
|
Ascites | 2 | 2020 | 336 | 0.300 |
Why?
|
Postoperative Hemorrhage | 1 | 2012 | 418 | 0.300 |
Why?
|
Hypertension | 6 | 2024 | 8616 | 0.300 |
Why?
|
Calcinosis | 2 | 2020 | 1475 | 0.300 |
Why?
|
Dizziness | 2 | 2021 | 269 | 0.300 |
Why?
|
Renal Replacement Therapy | 3 | 2021 | 282 | 0.300 |
Why?
|
Renal Artery | 2 | 2020 | 355 | 0.290 |
Why?
|
Nitrogen Isotopes | 1 | 2006 | 80 | 0.260 |
Why?
|
Cyanides | 1 | 2006 | 82 | 0.260 |
Why?
|
Career Choice | 1 | 2012 | 769 | 0.260 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1107 | 0.260 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2017 | 16040 | 0.250 |
Why?
|
Graft Survival | 2 | 2020 | 3904 | 0.250 |
Why?
|
Carbon Isotopes | 1 | 2006 | 453 | 0.250 |
Why?
|
Obesity | 3 | 2017 | 13085 | 0.240 |
Why?
|
Kidney Function Tests | 3 | 2017 | 684 | 0.240 |
Why?
|
Mass Spectrometry | 2 | 2017 | 2195 | 0.240 |
Why?
|
Isotope Labeling | 1 | 2006 | 390 | 0.240 |
Why?
|
Antihypertensive Agents | 3 | 2024 | 2028 | 0.240 |
Why?
|
Sodium | 3 | 2020 | 1591 | 0.230 |
Why?
|
Kidney Failure, Chronic | 4 | 2021 | 2504 | 0.230 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2815 | 0.220 |
Why?
|
Kidney Neoplasms | 1 | 2020 | 4282 | 0.220 |
Why?
|
Antioxidants | 1 | 2011 | 1671 | 0.220 |
Why?
|
Decision Support Systems, Clinical | 2 | 2024 | 1177 | 0.220 |
Why?
|
Middle Aged | 36 | 2024 | 223083 | 0.210 |
Why?
|
Accidental Falls | 2 | 2021 | 1079 | 0.210 |
Why?
|
Humans | 67 | 2024 | 766117 | 0.200 |
Why?
|
Osmolar Concentration | 2 | 2020 | 655 | 0.200 |
Why?
|
Uric Acid | 2 | 2021 | 809 | 0.190 |
Why?
|
Kidney Transplantation | 2 | 2020 | 4277 | 0.180 |
Why?
|
Female | 43 | 2024 | 396233 | 0.180 |
Why?
|
Complement C3 | 2 | 2020 | 424 | 0.180 |
Why?
|
Carrier Proteins | 1 | 2014 | 4910 | 0.180 |
Why?
|
Inosine | 1 | 2021 | 129 | 0.180 |
Why?
|
Ambulatory Care | 1 | 2012 | 2778 | 0.180 |
Why?
|
Male | 40 | 2024 | 363935 | 0.180 |
Why?
|
Complement C1q | 1 | 2020 | 83 | 0.180 |
Why?
|
Aged | 28 | 2024 | 171219 | 0.180 |
Why?
|
Sclerosis | 1 | 2020 | 211 | 0.170 |
Why?
|
Sodium Fluoride | 1 | 2020 | 60 | 0.170 |
Why?
|
Hematinics | 1 | 2023 | 282 | 0.170 |
Why?
|
Calcium Oxalate | 1 | 2020 | 75 | 0.170 |
Why?
|
Logistic Models | 6 | 2021 | 13273 | 0.170 |
Why?
|
Hypocalcemia | 1 | 2021 | 205 | 0.170 |
Why?
|
DNA | 1 | 2013 | 7193 | 0.170 |
Why?
|
Boston | 7 | 2021 | 9335 | 0.170 |
Why?
|
Hepatitis B Vaccines | 1 | 2021 | 178 | 0.170 |
Why?
|
Erythropoiesis | 2 | 2023 | 691 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2000 | 723 | 0.160 |
Why?
|
Critical Illness | 1 | 2012 | 2749 | 0.160 |
Why?
|
Curriculum | 1 | 2013 | 3784 | 0.160 |
Why?
|
Phosphorus | 1 | 2020 | 336 | 0.160 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5889 | 0.160 |
Why?
|
Genetic Variation | 1 | 2014 | 6612 | 0.160 |
Why?
|
Atrophy | 2 | 2020 | 1629 | 0.150 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 436 | 0.150 |
Why?
|
Mastocytosis | 1 | 2000 | 150 | 0.150 |
Why?
|
Liposarcoma | 1 | 2020 | 288 | 0.150 |
Why?
|
Urinalysis | 2 | 2017 | 369 | 0.140 |
Why?
|
omega-N-Methylarginine | 1 | 2017 | 108 | 0.140 |
Why?
|
Sodium-Bicarbonate Symporters | 1 | 2017 | 30 | 0.140 |
Why?
|
Adult | 25 | 2023 | 223139 | 0.140 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2017 | 3796 | 0.140 |
Why?
|
Graft Rejection | 4 | 2020 | 4504 | 0.140 |
Why?
|
Fluorine Radioisotopes | 1 | 2020 | 399 | 0.140 |
Why?
|
Risk Factors | 13 | 2021 | 74857 | 0.130 |
Why?
|
Risk Assessment | 7 | 2018 | 24276 | 0.130 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 425 | 0.130 |
Why?
|
Ethics, Research | 1 | 2018 | 178 | 0.130 |
Why?
|
Fibrosis | 2 | 2020 | 2073 | 0.130 |
Why?
|
Histidine | 1 | 2017 | 301 | 0.130 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2017 | 110 | 0.130 |
Why?
|
Hematuria | 2 | 2020 | 232 | 0.130 |
Why?
|
Disease Progression | 4 | 2021 | 13616 | 0.130 |
Why?
|
Mast Cells | 2 | 2000 | 1404 | 0.130 |
Why?
|
Hematoma | 1 | 2020 | 765 | 0.130 |
Why?
|
Retrospective Studies | 15 | 2023 | 81565 | 0.120 |
Why?
|
Hypotension | 1 | 2021 | 885 | 0.120 |
Why?
|
Hepatitis B | 1 | 2021 | 709 | 0.120 |
Why?
|
Erythropoietin | 1 | 2019 | 716 | 0.120 |
Why?
|
Uromodulin | 1 | 2014 | 49 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12235 | 0.120 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2014 | 63 | 0.120 |
Why?
|
Drainage | 1 | 2020 | 1182 | 0.120 |
Why?
|
International Normalized Ratio | 1 | 2016 | 382 | 0.120 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3432 | 0.120 |
Why?
|
Blood Coagulation Factors | 1 | 2016 | 372 | 0.110 |
Why?
|
Hypertension, Renal | 1 | 2014 | 135 | 0.110 |
Why?
|
Kidney Calculi | 2 | 2021 | 458 | 0.110 |
Why?
|
Potassium | 2 | 2023 | 1312 | 0.110 |
Why?
|
Heme Oxygenase-1 | 1 | 2016 | 364 | 0.110 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2020 | 789 | 0.110 |
Why?
|
Plasma | 1 | 2017 | 583 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2019 | 975 | 0.110 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15403 | 0.110 |
Why?
|
Glycine | 1 | 2017 | 671 | 0.110 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2015 | 156 | 0.110 |
Why?
|
Enzyme Inhibitors | 2 | 2001 | 3722 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12529 | 0.100 |
Why?
|
Alleles | 2 | 2014 | 6892 | 0.100 |
Why?
|
Lysine | 1 | 2017 | 994 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2016 | 412 | 0.100 |
Why?
|
Hypercalciuria | 1 | 2012 | 31 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2023 | 2136 | 0.100 |
Why?
|
Hyperoxaluria | 1 | 2012 | 33 | 0.100 |
Why?
|
Citric Acid | 1 | 2012 | 124 | 0.100 |
Why?
|
Prognosis | 6 | 2023 | 29912 | 0.090 |
Why?
|
Cisplatin | 1 | 2018 | 1654 | 0.090 |
Why?
|
Administration, Oral | 1 | 2019 | 4016 | 0.090 |
Why?
|
Cystatin C | 1 | 2013 | 272 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2021 | 1257 | 0.090 |
Why?
|
Sarcopenia | 1 | 2016 | 378 | 0.090 |
Why?
|
Cohort Studies | 6 | 2021 | 41684 | 0.090 |
Why?
|
Incidence | 4 | 2020 | 21513 | 0.090 |
Why?
|
Clonal Anergy | 1 | 2011 | 169 | 0.090 |
Why?
|
Receptors, Growth Factor | 2 | 2001 | 324 | 0.090 |
Why?
|
Cadherins | 1 | 2014 | 900 | 0.080 |
Why?
|
Aged, 80 and over | 8 | 2023 | 59515 | 0.080 |
Why?
|
Heart Failure | 3 | 2023 | 11837 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2879 | 0.080 |
Why?
|
Genotype | 2 | 2014 | 13028 | 0.080 |
Why?
|
Indoles | 4 | 2001 | 1833 | 0.080 |
Why?
|
Hospital Mortality | 2 | 2013 | 5340 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2015 | 5300 | 0.080 |
Why?
|
Needles | 1 | 2012 | 460 | 0.080 |
Why?
|
Time Factors | 5 | 2020 | 40108 | 0.080 |
Why?
|
Job Satisfaction | 1 | 2012 | 548 | 0.080 |
Why?
|
Age Distribution | 1 | 2014 | 2865 | 0.080 |
Why?
|
Vaccination | 1 | 2021 | 3431 | 0.080 |
Why?
|
Plaque, Atherosclerotic | 1 | 2020 | 1529 | 0.080 |
Why?
|
Podocytes | 1 | 2012 | 389 | 0.080 |
Why?
|
Prospective Studies | 7 | 2021 | 54812 | 0.070 |
Why?
|
Syncope | 2 | 2021 | 431 | 0.070 |
Why?
|
Parathyroid Hormone | 1 | 2015 | 1790 | 0.070 |
Why?
|
Warfarin | 1 | 2016 | 1494 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2469 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15882 | 0.070 |
Why?
|
Genetic Loci | 1 | 2017 | 2630 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15647 | 0.070 |
Why?
|
Phenotype | 2 | 2017 | 16716 | 0.070 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 26290 | 0.070 |
Why?
|
Metabolomics | 1 | 2017 | 1667 | 0.070 |
Why?
|
Nutrition Surveys | 1 | 2015 | 1735 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2885 | 0.070 |
Why?
|
Odds Ratio | 2 | 2017 | 9657 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2012 | 2476 | 0.070 |
Why?
|
Gene Frequency | 1 | 2014 | 3623 | 0.070 |
Why?
|
Dyslipidemias | 1 | 2014 | 871 | 0.070 |
Why?
|
Proteinuria | 2 | 2023 | 606 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2013 | 1536 | 0.070 |
Why?
|
Methicillin Resistance | 1 | 2007 | 198 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 931 | 0.060 |
Why?
|
Pyrroles | 3 | 2001 | 1120 | 0.060 |
Why?
|
Length of Stay | 4 | 2021 | 6490 | 0.060 |
Why?
|
Polymorphism, Genetic | 1 | 2016 | 4249 | 0.060 |
Why?
|
Risk | 2 | 2018 | 9599 | 0.060 |
Why?
|
Hospitalization | 3 | 2020 | 10811 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2012 | 1470 | 0.060 |
Why?
|
Quality Improvement | 1 | 2021 | 3849 | 0.060 |
Why?
|
Ions | 1 | 2006 | 254 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5090 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2020 | 3186 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1541 | 0.060 |
Why?
|
Heroin Dependence | 1 | 2005 | 174 | 0.060 |
Why?
|
Radiography | 1 | 2015 | 6943 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8882 | 0.060 |
Why?
|
Soft Tissue Infections | 1 | 2005 | 166 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2898 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2012 | 1520 | 0.050 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2001 | 1621 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2016 | 3617 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4780 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6544 | 0.050 |
Why?
|
Community-Acquired Infections | 1 | 2007 | 470 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2012 | 3501 | 0.050 |
Why?
|
Neoplasms | 3 | 2020 | 22344 | 0.050 |
Why?
|
Zebrafish | 1 | 2014 | 3035 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3928 | 0.050 |
Why?
|
Receptors, Chemokine | 2 | 2001 | 651 | 0.050 |
Why?
|
Portugal | 1 | 2021 | 91 | 0.050 |
Why?
|
Homeostasis | 1 | 2012 | 3338 | 0.050 |
Why?
|
Genome-Wide Association Study | 3 | 2017 | 12803 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 14066 | 0.050 |
Why?
|
Adolescent | 3 | 2020 | 88819 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3682 | 0.040 |
Why?
|
Patient Readmission | 3 | 2021 | 3283 | 0.040 |
Why?
|
Hemostasis, Surgical | 1 | 2020 | 128 | 0.040 |
Why?
|
Prevalence | 2 | 2016 | 15827 | 0.040 |
Why?
|
Chemokines, CXC | 1 | 2001 | 417 | 0.040 |
Why?
|
Bacteremia | 1 | 2007 | 988 | 0.040 |
Why?
|
Stem Cell Factor | 1 | 2000 | 194 | 0.040 |
Why?
|
Emergency Service, Hospital | 3 | 2021 | 7871 | 0.040 |
Why?
|
Critical Care | 1 | 2012 | 2714 | 0.040 |
Why?
|
Animals | 7 | 2014 | 168800 | 0.040 |
Why?
|
Renal Dialysis | 2 | 2023 | 1791 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2000 | 320 | 0.040 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2021 | 410 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2014 | 14747 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22228 | 0.040 |
Why?
|
Electrophoresis, Capillary | 1 | 1999 | 63 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2007 | 1423 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14645 | 0.040 |
Why?
|
Telemedicine | 1 | 2016 | 3108 | 0.040 |
Why?
|
Clostridium Infections | 1 | 2005 | 563 | 0.040 |
Why?
|
Radiation Tolerance | 1 | 2001 | 475 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2021 | 391 | 0.040 |
Why?
|
Chemokines | 2 | 2001 | 959 | 0.040 |
Why?
|
Electronic Health Records | 3 | 2021 | 4863 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2023 | 736 | 0.040 |
Why?
|
Staphylococcal Infections | 1 | 2007 | 1393 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2021 | 65219 | 0.040 |
Why?
|
Aldosterone | 1 | 2023 | 881 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2001 | 555 | 0.040 |
Why?
|
Reminder Systems | 1 | 2021 | 388 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20137 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12130 | 0.040 |
Why?
|
Cachexia | 1 | 1999 | 200 | 0.040 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1999 | 505 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2024 | 968 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2021 | 441 | 0.030 |
Why?
|
Hemoglobins | 1 | 2023 | 1531 | 0.030 |
Why?
|
Transplantation Immunology | 1 | 1999 | 540 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1729 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 59868 | 0.030 |
Why?
|
Ireland | 2 | 2007 | 171 | 0.030 |
Why?
|
Blood Protein Electrophoresis | 1 | 2016 | 65 | 0.030 |
Why?
|
Cryoglobulins | 1 | 2016 | 58 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2005 | 1761 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2023 | 1513 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 859 | 0.030 |
Why?
|
Blood Pressure | 2 | 2021 | 8532 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2000 | 1742 | 0.030 |
Why?
|
Body Mass Index | 3 | 2021 | 13046 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2023 | 1276 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2012 | 7850 | 0.030 |
Why?
|
Complement C4 | 1 | 2016 | 208 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 22341 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2011 | 10433 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2653 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2011 | 10260 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18076 | 0.030 |
Why?
|
Drug Design | 1 | 2000 | 1040 | 0.030 |
Why?
|
Point Mutation | 1 | 2000 | 1591 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13635 | 0.030 |
Why?
|
United States | 2 | 2013 | 72920 | 0.030 |
Why?
|
Signal Transduction | 2 | 2012 | 23605 | 0.030 |
Why?
|
Urine | 1 | 2016 | 363 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2000 | 3584 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1811 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 2 | 2001 | 2046 | 0.030 |
Why?
|
Diet | 1 | 2012 | 8087 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2020 | 1307 | 0.030 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2016 | 297 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15808 | 0.030 |
Why?
|
Sex Factors | 3 | 2018 | 10614 | 0.030 |
Why?
|
Urea | 1 | 2016 | 449 | 0.030 |
Why?
|
Blood Proteins | 1 | 1999 | 1186 | 0.030 |
Why?
|
Ligands | 1 | 2000 | 3274 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1613 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2915 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1592 | 0.030 |
Why?
|
Cell Count | 1 | 2016 | 1825 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3107 | 0.020 |
Why?
|
Eosinophils | 1 | 2016 | 946 | 0.020 |
Why?
|
Retina | 1 | 2001 | 2646 | 0.020 |
Why?
|
Mutation | 2 | 2013 | 30209 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 1999 | 4860 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18386 | 0.020 |
Why?
|
Iodohippuric Acid | 1 | 1989 | 8 | 0.020 |
Why?
|
Physicians, Primary Care | 1 | 2016 | 622 | 0.020 |
Why?
|
Piperazines | 1 | 2000 | 2547 | 0.020 |
Why?
|
Pentetic Acid | 1 | 1989 | 208 | 0.020 |
Why?
|
Stroke Volume | 1 | 2023 | 5595 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2001 | 4521 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11035 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8525 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3798 | 0.020 |
Why?
|
Mice | 3 | 2012 | 81839 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2001 | 3307 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7600 | 0.020 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2001 | 658 | 0.020 |
Why?
|
Hospital Costs | 1 | 2013 | 955 | 0.020 |
Why?
|
Primary Health Care | 1 | 2024 | 4736 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12426 | 0.020 |
Why?
|
Health Resources | 1 | 2013 | 951 | 0.020 |
Why?
|
Autoantibodies | 1 | 2016 | 2114 | 0.020 |
Why?
|
Glioblastoma | 1 | 2001 | 3458 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12827 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 1989 | 645 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2007 | 494 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12061 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10380 | 0.010 |
Why?
|
Registries | 1 | 2021 | 8347 | 0.010 |
Why?
|
Consensus | 1 | 2013 | 3202 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2782 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8724 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5988 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4443 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5367 | 0.010 |
Why?
|
Receptors, CXCR3 | 1 | 2001 | 240 | 0.010 |
Why?
|
Patient Discharge | 1 | 2013 | 3465 | 0.010 |
Why?
|
Chemokine CXCL10 | 1 | 2001 | 310 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2844 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2001 | 748 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2001 | 870 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 30233 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 671 | 0.010 |
Why?
|
Retinal Neovascularization | 1 | 2001 | 286 | 0.010 |
Why?
|
Lymphokines | 1 | 2001 | 905 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39243 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 559 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2001 | 1885 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2001 | 12775 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1241 | 0.010 |
Why?
|
Proteoglycans | 1 | 1999 | 794 | 0.010 |
Why?
|
Retinal Vessels | 1 | 2001 | 848 | 0.010 |
Why?
|
Child | 1 | 2021 | 80573 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 20700 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6102 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 4909 | 0.010 |
Why?
|
Cell Survival | 1 | 2001 | 5747 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2627 | 0.010 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 1989 | 67 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2001 | 4423 | 0.000 |
Why?
|
Myocardium | 1 | 2001 | 4766 | 0.000 |
Why?
|
Renal Circulation | 1 | 1989 | 288 | 0.000 |
Why?
|
Iodine Radioisotopes | 1 | 1989 | 1029 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9445 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2000 | 11906 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1999 | 18321 | 0.000 |
Why?
|
Inflammation | 1 | 1999 | 10860 | 0.000 |
Why?
|
Aging | 1 | 1989 | 8723 | 0.000 |
Why?
|